Vitae Pharmaceuticals' IPO

Vitae Pharmaceuticals raised a round of funding on September 24, 2014. Investors include Public.

Vitae Pharmaceuticals is a clinical stage biopharmaceutical company discovering and developing a portfolio of small molecule compounds that address disease areas, including: chronic kidney disease, di…

Articles about Vitae Pharmaceuticals' IPO: